Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05140265 · ClinicalTrials.gov registry record
De-identified UNMH EEG Corpus Database Creation With Fully De-identified Clinical Information
A clinical trial of Epilepsy and Seizures, sponsored by University of New Mexi.
- Recruiting
- Registry status
- 20,000
- Enrollment target
- 1
- Study location
NCT05140265: Recruiting study of Epilepsy and Seizures, sponsored by University of New Mexi.
NCT05140265 is a study of Epilepsy and Seizures that is actively recruiting participants, run by University of New Mexi. The registered enrollment target is 20,000 participants, above the 828-participant average among 160 other Epilepsy trials with a reported enrollment target (2315% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05140265, a study of Epilepsy and Seizures, is actively recruiting participants, sponsored by University of New Mexi.
- RECRUITING
- Registry status
- 20,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This proposal outlines the steps required for the creation of a pilot database of EEG recordings and de-identified medical records from patients internally referred within the UNMH Comprehensive Epilepsy Center. The UNMH EEG Corpus would be the first database of its kind. Other public databases contain either patient EEG signals or medical records, but without both kinds of information, it is impossible to relate pre-treatment neurobiomarkers with post-treatment prognosis. The database will also contain information that can improve seizure localization based off of scalp and intracranial EEG, and the requisite data for the creation of algorithms that forecast seizure activity; a development that could ultimately lead to novel responsive neural stimulation procedures that suppress seizures before they begin.
Primary Outcome
Fully de-identified database creation matching between EEG and clinical data for adult patients of 18 years or older who underwent EEG study at UNMH from 2007 till 2027
Conditions Studied
Study Locations (1)
New Mexico
- University of New Mexico Health Science - Albuquerque
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20,000 participants |
| Start Date | 2021-10-11 |
| Est. Completion | 2030-12-31 |
What NCT05140265 shows while recruiting
NCT05140265 is an observational study that tracks outcomes without assigning an intervention. Its 20,000 participants enrollment target places it among the larger protocols in the corpus, above the 828-participant average among 160 other Epilepsy trials with a reported enrollment target (2315% higher).
The record links to 3 conditions, with Epilepsy appearing as the primary indexed condition, and to 0 interventions.
NCT05140265 reports a single indexed study location in New Mexico.
Frequently Asked Questions
What is clinical trial NCT05140265 about?
NCT05140265 is a clinical study titled "De-identified UNMH EEG Corpus Database Creation With Fully De-identified Clinical Information". This proposal outlines the steps required for the creation of a pilot database of EEG recordings and de-identified medical records from patients internally referred within the UNMH Comprehensive Epilepsy Center. The UNMH EEG Corpus would be the first database of its kind. Other public databases cont...
What is the current status of trial NCT05140265?
This trial is currently recruiting. The enrollment target is 20,000 participants. The study started on 2021-10-11. Estimated completion is 2030-12-31.
What conditions does trial NCT05140265 study?
This clinical trial studies the following conditions: Epilepsy, Seizures, Status Epilepticus.
Who is sponsoring clinical trial NCT05140265?
This trial is sponsored by University of New Mexi, which has 76 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05140265 being conducted?
This trial has 1 study location across New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Epilepsy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05140265's enrollment target sits among peer trials
20,000 2nd of 160 the highest of 160 other Epilepsy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Epilepsy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Retrospective Survey-based Multicenter Study to Delineate the Molecular and Phenotypic Spectrum of Epilepsy-dyskinesia Syndromes
RECRUITING
-
Diagnosing Epilepsy To EffeCT Change Long-Term Follow-Up
RECRUITING
-
SeizEAR Safety Study
RECRUITING · NA
-
Physiological-based Pharmacokinetics Approach to Medication Exposure During Pregnancy and Breastfeeding
RECRUITING
-
Tumor Related Epilepsy
RECRUITING
-
Study to Evaluate the Relative Bioavailability of a New Formulation of NPT 2042 Soft-Gelatin Capsules Compared to the Original Formulation of NPT 2042
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00271180 · 20,000 participants
Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products
- NCT00830557 · 20,000 participants
Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders
- NCT00900471 · 20,000 participants
Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors
- NCT02735707 · 20,000 participants · Phase 3
Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI